Skip to content

Home
Our research
Market
Press release
Reports
Plans
Partnering
About us

Menu

Home
Our research
Market
Press release
Reports
Plans
Partnering
About us

Dokument inför årsstämman 13 juni 2016

Dokument inför årsstämman finns publicerade på sidan Investerare/Bolagsstyrning.

Contact us

Kristian Lykke Fick

Twitter Linkedin Facebook Youtube

As part of Coegin Pharma AB’s hub & spoke “portfolio” business model, with clear benefits to investors, Coegin Pharma AB has established the Swedish portfolio company Follicum AB to further develop a highly promising novel and proprietary dermatological drug candidate FOL005. Follicum AB will primarily be managed and financed separately from Coegin Pharma AB.

© All Rights Reserved